Refine your results

to


Search

Starting metformin reduces risks for CV events, death in type 2 diabetes

Show Citation

April 20, 2017

AUTHORS:

Svensson E, Baggesen LM, Johnsen SP, Pedersen L, Nørrelund H, Buhl ES, Haase CL, Thomsen RW.

OBJECTIVE:

We investigated the association of early achieved HbA1c level and magnitude of HbA1c reduction with subsequent risk of cardiovascular events or death in patients with type 2 diabetes who initiate metformin. ...

Advertisement
Advertisement